Our Expertise

Build value and drive convenience through innovative medical device technology

For the medical devices segment in the healthcare industry, VSI provides innovation around software, mechanical and electronic engineering to design, develop and validate a new generation of connected products. Our connected health devices are built using wireless technologies, IoT, and Artificial Intelligence platforms such as VSI HOLMESTM to simplify diagnosis and treatment, enhance patient and caregiver convenience and meet stringent regulatory norms.

Our Success Stories

Pharmaceutical & Life Sciences

Life Sciences firm saves lives by tracking outbreaks & fortifying supply chains

Digital surveillance system with big-data analytics & cognitive computing ensuring critical medical supply

What we Think

Digital Operations and Platforms

Five Challenges in using Predictive Analytics to Improve Patient Outcomes

Predicting medical device failures is critical to minimize service costs. Here is how companies can leverage predictive…

EMRGateway - Interoperability solution for medical devices

The need for “plug-and-play” interoperability – the ability to take a medical device out of its box and easily make it…

Medical devices: The Trend of M2M connectivity

Explore how M2M enables proactive service, allows for consumption-based business models and drives recurring revenue…

(De)sign Of Things to Come

Medical device companies weave new business models to provide value-added services

What we Do

Technology Landscaping

Differentiate, innovate and lead

Homecare

Improved patient care the remote way

Remote Patient Monitoring

Differentiate, innovate and lead

Field Service Transformation

Increase the value of medical devices

Product Complaints Management

Smooth and effective complaints handling

Emerging Markets

Emerging markets, new potential

VSI iX Solutions for Medical Devices Field Services

Delivering superior field services using augmented reality

Segments

R&D and Engineering Services

Sales and Marketing

Quality Assurance and Regulatory Affairs

Manufacturing and Supply Chain

Post Market

Scroll to Top

What We Think

A New Era for Medical Device Traceability with Digital Product Passports
Leveraging AI to Enable a Single Source of Truth for Pharma and Food Supply Chains
Achieving Diversity and DEPICT Act Compliance in Clinical Trials

According to one estimate, 50% of US clinical trial participants come from 1-2% of all ZIP codes. Members of Black, Latino and Asian communities are massively underrepresented in clinical trials.

Key Strategies for Life Sciences Cloud Innovations
Smart Cities and Health Equity

At the intersection of technology and healthcare, there’s often an uncomfortable question about equity: Even if a new medical innovation can deliver impressive outcomes, what if the intervention remains too expensive to benefit most patients? Recently, that issue has become front and center in the public health vs. precision healthcare debate.

Navigating Health Equity: Expert Panel Insights in Life Sciences
IDC Spotlight: Digital and Clinical Biomarkers
As digital health technologies accumulate more and more patient data, stakeholders across the healthcare value chain are looking to digital biomarkers as crucial counterparts to clinical biomarker data
Everest Group – Vsi: Pharmacovigilance of the Future

Transformation Roadmap for Pharmacovigilance in Digital Era

The Role of Analytics in the Life Sciences Industry

In the Consumer Goods (CG) industry, competition is primarily driven by brand recognition, product innovation, and price. Other aspects that are also critical for success include the ability to meet consumer preferences, product quality, and promotions.

Data Lakes can transform Mergers & Acquisitions

An unprecedented rise of the failing M&A’s has resulted in enormous financial and operational losses. Data Lakes has successfully addressed the problem by offering flexible data options for real time reporting,application integration and simplifying information systems.

Your Digital Doctor is here

Today’s patients see digital technology as an enabler in their journey to wellness – they are always connected, and this has fundamentally changed their expectations and behaviors. Read on to know more how the technology landscape is enabling this revolution in healthcare.

NextGen Pharma takes ‘Smart’ Strides with Internet of Things

Digitization of processes and data across the value chain along with the emergence of Internet of Things (IoT) has transformed the Pharma industry. Although IoT is still in its nascent stages of adoption in the Life Sciences industry, the use of smart devices and machine-to-machine (M2M) communication leveraging SMAC technologies comes at a time when the industry is grappling with patent cliffs and declining R&D productivity

IDC Tech Spotlight: Transforming Life Sciences into Cloud – Native Business

The market is seeing that the consumer brands are increasingly pivoting to Direct to Consumer (DTC) model. This is seeing increasing demand for distribution centers (DC’s) to support online fulfillment.

Blockchain: A Future- Proof Enabler of the Evolving Life Sciences Industry Paradigm

Enabling the Apparel and Fashion Industry to transition to the Next-gen Digital World

mHealth Adoption in India

Over the past two decades, there has been a steady rise in online traffic caused by consumers turning to the internet and social media to shop for everyday essentials, rather than brick-and-mortar stores.

The Big Data Magic for Pharma

Digital transformation is a term much-used in corporate circles but ask what it means and each one has a different answer depending on their orientation

Life Sciences - Striking the Right Social Balance

Consumer Goods Companies need to use Data Effectively to understand Consumers’ needs so they can Deliver on the Promise made to Consumers

Role of Manufacturing Analytics in Pharma

The efficiency of the extended supply chain is dependent on a strong TPO module and the extent of its utilization

Will the Healthcare Information Technology Meet Stakeholder Expectations?

The smartphone or tablet you’re reading this blog on was, in all likelihood, assembled in an emerging market economy.

Driving Diversity and Equity in Clinical Trials

On the morning of June 24, 2016, residents of Great Britain woke up to the news that their country was going to leave the European Union, as a result of the Brexit referendum vote held the previous day

Artificial Intelligence, the silver bullet for speed in Clinical Development

While conversing with a CPG Director at a POI event in Budapest, he mentioned how some 28 years ago, an article in the Harvard Business Review offered an assessment of the difficulties facing manufacturers in the fast-moving consumer goods sector.

Clinical Trial Management System

Control over deliveries has become exceedingly important since the trend of consumers and shoppers buying directly from Consumer Goods (CG) companies –largely through online and mobile channels are forcing Consumer Goods (CG) companies to work harder to get closer to their end-consumers and increase brand recall.

Healthcare & Life Sciences Communiqué Edition 2

In times of great stress that move people and societies to adapt to new circumstances, businesses that sense the potential inflections in their customers’ lives and boldly prepare for a different future not only survive, but thrive.

Technology: Driving the Pharma Industry in More Ways Than You Think

Technology enablement plays a crucial role in tracking customer needs that are expressed through different channels; a platform based approach will help telcos improve customer satisfaction and thereby improve revenues. It’s time for telcos to relook at Service Assurance strategy.